Login
$CNXC
$31.48 -$0.53 (1.66%) Live

$CNXC SEC Filings

Filed On Filing
21 Oct 2026 SCHEDULE 13G/A
07 Oct 2026 S-8
07 Oct 2026 10-Q
29 Sep 2026 8-K: Results of Operations and Financial Condition

Newark, Calif., Sept. 29, 2026 – Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal third quarter ended August 31, 2026.

18 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

On September 15, 2026, Concentrix Corporation (the “Company”) and Cormac Twomey, the Company’s Executive Vice President, Customer Success, agreed that Mr. Twomey will step down from his role with the Company, effective December 31, 2026....

14 Aug 2026 SCHEDULE 13G
13 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 SCHEDULE 13G/A
24 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation
09 Jul 2026 Form 4: Caldwell Christopher A, Director

Bought 1,000 shares ($21.2K)

08 Jul 2026 SCHEDULE 13G/A
02 Jul 2026 10-Q
29 Jun 2026 8-K: Results of Operations and Financial Condition
14 May 2026 SCHEDULE 13G
06 May 2026 SCHEDULE 13G
01 May 2026 8-K: Departure/Election of Directors or Officers; Compensation
01 May 2026 SCHEDULE 13D/A
01 May 2026 Form 4: Groupe Bruxelles Lambert, 10% owner and 4 others

Sold 6,000,000 shares ($134M)

29 Apr 2026 144
27 Apr 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support